Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6064796 | 0.98 | CHRM3 (0.32) | CHRM3CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL7199231 | 0.98 | CHRM3 (0.32) | CHRM3CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL6064899 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL7196141 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL7630694 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL7630700 | 0.81 | — | — | |
| Hydrochloric Acid SCHEMBL1538415 | 0.79 | — | — | |
| SCHEMBL6300446 | 0.77 | — | — | |
| SCHEMBL27669416 | 0.76 | — | — | |
| SCHEMBL4914086 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1778606-B1 | SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | CHEVRON PHILLIPS CHEMICAL CO (US) | 2009-11-25 | — | — | EP | disclosed |
| US-7420097-B2 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2008-09-02 | — | — | US | disclosed |
| CN-1997614-A | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL CO (US) | 2007-07-11 | — | — | CN | disclosed |
| EP-1778606-A1 | SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | Chevron Phillips Chemical Company (US) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006004669-A1 | IMPROVED SYNTHESIS OF 6-ARYL-6-ALKYL FULVENES, 6-ARYL-6-ALKENYL FULVENES, AND RELATED COMPOUNDS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2006-01-12 | — | — | WO | disclosed |
| US-20050288524-A1 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | CHEVRON PHILLIPS CHEMICAL COMPANY | 2005-12-29 | — | — | US | disclosed |
| US-20050288461-A1 | Polymerization catalysts for producing polymers with low levels of long chain branching | CHEVRON PHILLIPS CHEMICAL COMPANY, L.P. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288524-A1 | Synthesis of 6-aryl-6-alkyl fulvenes, 6-aryl-6-alkenyl fulvenes, and related compounds | ANXA6, ARSA, CYP2A6 | CHRM3 2520/4885CHRM2 3046/4885CHRM1 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.